Equities analysts predict that Exponent, Inc. (NASDAQ:EXPO) will announce sales of $88.21 million for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Exponent’s earnings. The highest sales estimate is $89.81 million and the lowest is $86.60 million. Exponent reported sales of $82.72 million during the same quarter last year, which indicates a positive year-over-year growth rate of 6.6%. The firm is expected to announce its next quarterly earnings report on Thursday, February 7th.
On average, analysts expect that Exponent will report full-year sales of $357.59 million for the current year, with estimates ranging from $356.00 million to $359.18 million. For the next year, analysts expect that the business will report sales of $381.03 million, with estimates ranging from $371.80 million to $390.25 million. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover Exponent.
Exponent (NASDAQ:EXPO) last issued its quarterly earnings results on Thursday, October 18th. The business services provider reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. The company had revenue of $88.71 million for the quarter, compared to analyst estimates of $88.52 million. Exponent had a net margin of 13.98% and a return on equity of 20.92%. Exponent’s revenue was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.27 earnings per share.
In related news, VP Harri Kytomaa sold 3,000 shares of the business’s stock in a transaction on Monday, November 5th. The shares were sold at an average price of $51.50, for a total value of $154,500.00. Following the transaction, the vice president now owns 6,090 shares in the company, valued at $313,635. The transaction was disclosed in a document filed with the SEC, which is available through this link. 2.80% of the stock is owned by insiders.
Hedge funds have recently added to or reduced their stakes in the stock. Strs Ohio acquired a new position in Exponent in the second quarter valued at $101,000. Fort L.P. acquired a new position in Exponent in the second quarter valued at $117,000. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Exponent by 100.0% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,952 shares of the business services provider’s stock valued at $143,000 after purchasing an additional 1,476 shares in the last quarter. KBC Group NV bought a new stake in Exponent in the second quarter valued at $150,000. Finally, HPM Partners LLC bought a new stake in Exponent in the second quarter valued at $209,000. Institutional investors and hedge funds own 88.13% of the company’s stock.
Shares of NASDAQ:EXPO traded down $0.28 during mid-day trading on Tuesday, reaching $48.41. 1,404 shares of the company’s stock were exchanged, compared to its average volume of 224,872. The firm has a market cap of $2.50 billion, a PE ratio of 45.60 and a beta of 0.61. Exponent has a twelve month low of $34.90 and a twelve month high of $54.58.
The company also recently announced a quarterly dividend, which will be paid on Friday, December 21st. Investors of record on Friday, December 7th will be issued a $0.13 dividend. The ex-dividend date of this dividend is Thursday, December 6th. This represents a $0.52 annualized dividend and a yield of 1.07%. Exponent’s payout ratio is 48.60%.
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Recommended Story: Cash Flow
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.